This article will provide a brief overview of how disease-modifying therapies treat MS, as well as insight into the other various MS drugs used to treat flare-ups and daily symptoms.
How Do MS Drugs Work?
DMTs are “big-picture” drugs intended to improve the long-term outlook of a person’s disease. They work to decrease MS relapses (flares of symptoms), limit the number of lesions (areas of inflammation) on imaging tests, and slow the overall course of the disease.
There are more than 20 DMTs approved by the Food and Drug Administration (FDA). They vary in their mode of action, level of effectiveness, side effects, and delivery method (injection, oral, or IV infusion).
Injectable DMTs can be administered at home as a shot into one of your muscles (intramuscular) or beneath your skin (subcutaneous). Infused DMTs are given through a needle placed in your vein at a healthcare facility.
For example, the monoclonal antibodies Ocrevus (ocrelizumab), Kesimpta (ofatumumab), and Lemtrada (alemtuzumab) recognize and bind to selective docking sites on B cells or T cells.
Specifically, Ocrevus and Kesimpta work by destroying and removing B cells with a CD20 docking site. Lemtrada works by eliminating T cells or B cells with a specific CD52 docking site.
Another monoclonal antibody, Tysabri (natalizumab), also targets T cells. It sticks to a specific molecule on T cells (called α4-integrin). By binding to this molecule, T cells are hindered from traveling into the brain and spinal cord and damaging myelin.
Other, typically older, DMTs have a less clear or specific mode of action.
For instance, the oral drug Tecfidera (dimethyl fumarate) is believed to protect nerve cells from damage through anti-inflammatory and antioxidant properties.
Likewise, the beta-interferon drugs (e.g., Avonex or Betaseron) are manufactured versions of proteins that work to quiet down the inflammation that damages nerves in MS.
How Long Do MS Drugs Take to Work?
A 2020 study in Brain investigated the time it took for 10 different DMTs to reach their maximal effect in people with multiple sclerosis.
Results revealed that it took between three to seven months to reduce relapses and seven to 17 months for a delay in disease progression.
How Do You Know If It’s the Right Drug for You?
There are no set-in-stone guidelines for selecting an MS DMT.
Rather, you and your neurologist (a doctor specializing in diseases of the nervous system) will consider several factors like how aggressive your disease is and the drug’s safety profile and delivery method. Cost, accessibility, and lifestyle factors like plans for pregnancy are also important considerations.
Once you have selected and started a DMT, your neurologist will see you every three to six months.
During these follow-up appointments, your neurologist will monitor you for side effects and any signs of disease activity by inquiring about symptoms and performing a neurological examination.
They may also ask you questions using the Expanded Disability Status Scale (EDSS) tool to help track disease progression.
To check for silent lesions, which are areas of inflammation in the absence of symptoms, you will undergo periodic magnetic resonance imaging (MRI) scans of your brain and/or spinal cord.
If you experience a new severe relapse or multiple relapses, or if your MRI reveals new lesions, you may need to switch your DMT.
Drugs for Relapses
DMTs are intended to decrease the number and severity of MS relapses, but they do not treat individual relapses.
Treatment for an MS relapse is typically advised when symptoms negatively impact a person’s ability to function, such as trouble walking or losing your vision, or are particularly unpleasant, like numbness.
In such cases, a three-to-five-day course of corticosteroids (also called steroids), either Solumedrol (methylprednisolone) or prednisone, is usually prescribed. Solumedrol is administered as an IV infusion in a healthcare facility. Prednisone is taken by mouth at home.
Less commonly, neurologists prescribe intravenous immune globulin (IVIG) or adrenocorticotropic hormone (ACTH) gel injections to treat MS relapses.
Drugs for Daily Symptoms
DMTs do not treat daily MS symptoms like pain, fatigue, numbness, or spasticity (muscle tightness or stiffness preventing natural movement). Instead, separate medications (along with lifestyle behaviors and rehabilitation therapies) are used to manage the everyday symptoms of MS.
For example, if you are experiencing pain associated with spasticity, your neurologist may prescribe a muscle relaxant like Kemstro (baclofen) or Zanaflex (tizanidine).
For MS-related fatigue, your neurologist may prescribe a drug to promote wakefulness called Provigil (modafinil) or a stimulant called Ritalin (methylphenidate).
Summary
Numerous drugs are used to treat MS, including disease-modifying therapies (DMTs) and medications for relapses and specific symptoms. The primary goal of all DMTs is to prevent MS activity by reducing inflammation in the brain and spinal cord. DMTs do not treat MS relapses or symptoms
A Word From Verywell
Creating an MS treatment plan takes time and effort. Do your best to gain as much knowledge as you can about the various drug options available. Also, under the guidance of your neurologist, be sure to carefully review the side effect profiles of each drug and what you can realistically expect in terms of the drug’s benefit.
Nevertheless, DMTs decrease MS relapses and activity and delay disease progression. Therefore, while you can technically live with MS without medication, you may experience more frequent relapses and a higher level of disability over time.
There was an error. Please try again.
